Mosquito-borne alphaviruses are important causes of epidemic encephalomyelitis. Neuronal cell death during fatal alphavirus encephalomyelitis is immune-mediated; however, the types of cells involved and their regulation have not been determined. We show that the virus-induced inflammatory response was accompanied by production of the regulatory cytokine IL-10, and in the absence of IL-10, paralytic disease occurred earlier and mice died faster. To determine the reason for accelerated disease in the absence of IL-10, immune responses in the CNS of IL-10 −/− and wild-type (WT) mice were compared. There were no differences in the amounts of brain inflammation or peak virus replication; however, IL-10 −/− animals had accelerated and increased infiltration of CD4 +
IL-17A
+ and CD4 +
+ IFNγ + cells compared with WT animals. Th17 cells infiltrating the brain demonstrated a pathogenic phenotype with the expression of the transcription factor, Tbet, and the production of granzyme B, IL-22, and GM-CSF, with greater production of GM-CSF in IL-10 −/− mice. Therefore, in fatal alphavirus encephalomyelitis, pathogenic Th17 cells enter the CNS at the onset of neurologic disease and, in the absence of IL-10, appear earlier, develop into Th1/Th17 cells more often, and have greater production of GM-CSF. This study demonstrates a role for pathogenic Th17 cells in fatal viral encephalitis.
GM-CSF | Sindbis virus | immunopathology | viral encephalitis | interleukin-10 E ncephalitic arthropod-borne viruses are important causes of morbidity and mortality worldwide (1, 2) . In the Americas, the mosquito-borne alphaviruses infect neurons and cause outbreaks of encephalomyelitis with high mortality in horses and humans. In addition, Chikungunya virus, a newly emerging and rapidly spreading old-world alphavirus, can also cause neurologic disease (3) (4) (5) . The immune-mediated inflammatory response in the central nervous system (CNS) is necessary for virus clearance, but can also cause neuronal damage. Several lines of evidence suggest that fatal alphavirus encephalomyelitis is mediated by the immune response to virus infection rather than virus infection per se (6, 7) , but the components of the immune response involved in causing neuronal death and mechanisms for regulating this immunopathology have not been identified.
We have used a well-characterized model of fatal alphavirus encephalomyelitis to identify immune contributors to fatal disease. Neuroadapted Sindbis virus (NSV) infects neurons in the brain and spinal cord with a particular tropism for hippocampal and motor neurons and causes fatal paralytic disease in adult C57BL/6 mice (8) (9) (10) . Infected neurons die during this disease process, but neuronal death is caused by the immune response to infection rather than by damage from virus replication (7, 10) . Mice can be protected from fatal disease if the CNS inflammatory response is inhibited, despite the fact that this results in a failure of virus clearance (7, 11) . Studies of immunedeficient mice have implicated T cells in this immunopathologic process (6, 9) , but the types of T cells involved, their pathologic function, and the regulation of this response during fatal disease are not known. Interleukin (IL) 10 is a critical regulatory cytokine produced by many types of cells that determines the balance between inflammation and immune regulation by influencing antigen presentation, T-cell differentiation, cytokine production, and intensity of inflammation (12, 13) . During fatal CNS infection induced by intranasal inoculation of 4-6-wk-old C57BL/6J mice with 10 5 pfu NSV, Il10 mRNA was increased in both the brain and spinal cord (P < 0.0001; Fig. 1A ). To determine the importance of IL-10 production in the CNS during the induction of fatal encephalomyelitis, we compared the disease course of NSV-infected wildtype (WT) C57BL/6J mice to that of IL-10-deficient C57BL/6J mice (B6.129P2-Il10 tm1Cgn /J; IL-10
). Disease was accelerated in IL-10 −/− mice with more rapid onset of paralysis (P < 0.0001; Fig.  1C ) and earlier death (mean day of death was 8 d compared with 10 d, P < 0.0001; Fig. 1D ). Accelerated disease progression occurred during the time of Il10 mRNA increase in WT mice, 5-7 d after infection ( Fig. 1 A and C) . IL-10 deficiency did not affect virus replication or peak virus titers, although titers at day 7 suggest that virus clearance was delayed (Fig. 1B) .
To identify the reason for accelerated disease in the absence of IL-10, we first assessed the magnitude of the CNS inflammatory response by isolating and counting cells infiltrating the brain ( Fig.  2A) and by scoring hematoxylin and eosin (H&E)-stained coronal brain sections for inflammation ( Fig. 2 B and C) . The numbers of infiltrating cells and amount of inflammation increased through 7 d after infection, but these parameters were not different between WT and IL-10 −/− mice. To determine whether the relative proportions of myeloid and lymphoid cells contributing to the Significance Mosquito-borne alphaviruses are important causes of epidemic encephalomyelitis. The immune response plays an important role in disease; however, immune-mediated mechanisms of pathogenesis and regulation are not understood. In this study, we determined that a pathogenic Th17 response occurs during fatal alphavirus encephalitis. Furthermore, the regulatory cytokine, interleukin 10, plays an important role in modulating the pathogenic Th17 response. In the absence of interleukin 10, the Th17 response is increased in magnitude and displays a more pathogenic phenotype, resulting in accelerated disease progression. These findings are important for understanding the pathogenesis of virus infections in the central nervous system and the identification of therapeutic interventions that focus on immune modulation in the central nervous system. inflammatory process differed, we used flow cytometry for identification of cells isolated from the brain (Fig. 2 D-O ). There were no differences in numbers or percentages of microglia ( To determine whether increased neutrophil infiltration into the CNS was responsible for accelerated disease in IL-10 −/− mice, neutrophils were depleted using antibody to Ly6G or control antibody given at the time of infection and 4 d after infection (14) . Depletion of circulating neutrophils was confirmed to be greater than 90% by blood smears (Fig. S1A ) and greater than 65% in the brain (Fig. S1 B and C) . The presence or absence of neutrophils did not alter the disease course in IL-10 −/− mice ( Fig. S1 D and E) . Therefore, neither differences in numbers nor overall types of CNS inflammatory cells explained accelerated disease in the absence of IL-10.
As both CD8 + and CD4 + T cells have been implicated in immunopathologic processes during NSV infection (6), we next assessed the possibility that the absence of IL-10 led to functional differences in these cell populations even though overall numbers were similar. Flow cytometry and intracellular cytokine staining were used to measure production of the effector molecules TNFα, IFNγ, and granzyme B by CD8 + T cells isolated from the brain at 5 d (Fig. 3 A-G) and 7 d (Fig. 3 H-N Fig. 3B ), whereas the number and percentage of CD8 + T cells producing IFNγ (Fig. 3 D and E) and TNFα (Fig. 3 F and G) were similar. A decrease in CD8
+ T cells producing granzyme B in IL-10 −/− mice would be predicted to decrease, rather than increase, cytotoxicity, but could slow virus clearance (Fig. 1B) (15, 16) . At 7 d after infection, no differences were observed between WT and IL-10 −/− mice in the frequency or number of CD8 + T cells expressing IFNγ, TNFα, or granzyme B (Fig. 3 H-N) . Analysis of fluorescence intensity indicated that amounts of granzyme B per CD8 + T cell were similar in WT and IL-10 −/− mice ( Fig. 3 A and H). Therefore, differences in numbers or function of CD8 + T cells did not explain accelerated disease in IL-10 −/− mice.
IL-10 Deficiency Increases the Numbers of Th17 Cells in the CNS.
CD4
+ T cells can differentiate into several functional groups defined by transcription factor expression and cytokine production. Because both Th1 and Th17 subsets have been implicated in autoimmune disease in the CNS (17), we used flow cytometry and intracellular cytokine staining to analyze brain CD4
+ cells for production of signature cytokines IFNγ (Th1) and IL-17A (Th17) (Fig. 4) . At 5 d after infection, when signs of neurologic disease appear in IL-10 −/− mice (Fig. 1C) , the IFNγ-producing CD4
+ population was similar ( Fig. 4 A-C), but there was a fivefold increase in the frequency (2.97% vs. 14.62%, P = 0.0063; To assess the effect of IL-10 deficiency on Th17-related gene expression in the CNS, we compared the levels of mRNAs for Il17a and for the Th17-specific chemokine Ccl20 ( Fig. 4N ), but not the brain (Fig. 4M) .
Therefore, both Th1 and Th17 cells began infiltrating the CNS of WT mice coincident with the onset of paralysis and were present during fatal NSV infection. In the absence of IL-10, accelerated disease correlated with an increase in the Th17, but not the Th1, response. Th17 cells are polyfunctional, have multiple phenotypes, and can play both detrimental and beneficial roles in disease pathogenesis (19) (20) (21) . To determine the phenotype of the Th17 cells entering the brain at the onset of neurological disease, CD4
+ cells from the brain at 5 d after NSV infection were examined for production of granzyme B, IL-22, and GM-CSF, cytokines associated with a pathogenic phenotype in experimental autoimmune encephalomyelitis (EAE) (19) (20) (21) (Fig. 5 ). (Fig. 5A) . , n = 37; ****P < 0.0001.
Greater differences were observed for Th17 cell production of GM-CSF. In IL-10 −/− mice, both the proportion (23.8% vs. 15.7%, P = 0.0173; Fig. 5 A and B) and numbers (1.1 × 10 3 vs. 4.1 × 10 1 , P = 0.0268; Fig. 5C ) of Th17 cells producing GM-CSF were higher than in WT mice. Additionally, the Th17 cells in the brains of IL-10 −/− mice had higher mean fluorescence intensities for GM-CSF than those in the brains of WT mice, indicating a higher level of GM-CSF production per cell (P = 0.0179; Fig. 5 A and D) . Together, these data show that the Th17 cells in the CNS during fatal NSV infection have a pathogenic phenotype and that, in the absence of IL-10, the pathogenic Th17 response is amplified and GM-CSF production increased. A definitive role for a particular Th17 product could not be identified because neither treatment with neutralizing antibody to IL-17 nor GM-CSF improved the outcome in IL-10 −/− or WT mice compared with control antibody (Fig. S3 A-H) .
Th17 cells develop independently of Tbet and IFNγ, but in tissue can acquire expression of these signature Th1 factors along with an increase in pathogenicity (22) . An important pathogenic role is suggested by the target organ presence of IL-17A + IFNγ + Th1/Th17 cells during EAE and autoimmune colitis (21) and by the fact that mice deficient in the transcription factor Tbet are protected from development of EAE (23, 24) . Because pathogenic Th17 cells can develop into multifunctional pathogenic Th1/17 cells, we examined brain CD4
+ T cells for expression of Tbet and the Th17 transcription factor, RORγt, in conjunction with the production of IL-17A and IFNγ (Fig. 6) (Fig. 6 A and B) . In the absence of IL-10, however, in addition to an increase in the proportion of Th17 cells (8.98% vs. 2.53%, P = 0.0003), there was also an increase in the Th1/Th17 population (4.28% vs. 0.46%, P = 0.0262; Fig. 6 A and B) .
The IFNγ + cells in the brains of WT and IL-10 −/− mice expressed Tbet, with little expression of RORγt, consistent with classic Th1 cells (Fig. 6 C and D, Top) . The IL-17A + cells expressed RORγt, the canonical Th17 lineage transcription factor, as well as Tbet, a marker of pathogenicity ( Fig. 6 C and D 
IL-17A
+ cells in the brains of IL-10 −/− mice also expressed RORγt and Tbet (Fig. 6 C and D, Bottom) . These data show that populations of pathogenic Th17 cells are present in the CNS at the onset of neurological disease in WT and IL-10 −/− mice. The increased presence of Th1/Th17 cells in the absence of IL-10 suggests that these cells are regulated by IL-10 and may contribute to the accelerated disease progression. Discussion T-cell-mediated damage drives pathogenesis of fatal alphavirus encephalomyelitis. We identified Th1 and pathogenic Th17 cells in the CNS at the onset of neurological disease. IL-10 expression increased in the CNS after infection and was identified as a critical regulator of the Th17 and Th1/Th17 response. In the absence of IL-10, paralytic disease was accelerated concomitant with increased infiltration of pathogenic Th17 and Th1/Th17 cells into the CNS. Pathogenic Th17 cells expressed effector cytokines IL-17A, IL-22, granzyme B, and GM-CSF and transcription factors RORγt and Tbet, with a marked increase in production of GM-CSF in the absence of IL-10.
The role of IL-10 regulation of the immune response during viral encephalitis has received limited analysis. IL-10 has a protective role during acute coronavirus and flavivirus encephalitis in mice, but the mechanisms by which outcome is improved were not identified (25) (26) (27) . Although IL-10 deficiency can promote determined. The data represent the mean ± SEM from two to four independent experiments; *P < 0.05, **P < 0.01.
an overall increase in inflammation (28-30), this did not occur in alphavirus-induced encephalomyelitis. Rather, IL-10 deficiency facilitated a selective increase in the proportion of CD4 + T cells in the inflammatory response that were Th17 cells.
IL-10 directly inhibits both differentiation and proliferation of Th17 cells (31) (32) (33) , and IL-10 deficiency leads to an increase in Th17 cells in mice infected with leishmania (34), influenza virus (35) , and respiratory syncytial virus (RSV) (36) . During pulmonary infection with influenza virus, an increase in Th17 cells is associated with a better outcome, whereas for infection with RSV and leishmania, the disease was more severe. In none of these studies was the function or cytokine profile of the Th17 cells characterized to provide insight into how IL-10 modulated Th17-associated disease. During NSV infection of the CNS, IL-10 deficiency also led to more severe disease and an increase in Th17 cells. Functional characterization of the Th17 cells revealed a pathogenic phenotype with production of granzyme B, IL-22, and GM-CSF.
The effector function(s) of Th17 cells that cause neurologic disease are not clear, but multiple factors may contribute. IL-17 production is reported to be both protective and damaging (17, (37) (38) (39) (40) . IL-17 can induce neuronal cell death in vitro (41) , and EAE is attenuated in mice lacking IL-17 (42) . Neutralization of IL-17 did not improve outcome after NSV infection, but a role for IL-17 in neuronal damage cannot be excluded because of unknown CNS penetration of the antibody. Granzyme B induces neurotoxicity by activation of protease-activated G protein-coupled receptors on neurons (43) , and both granzyme B and IL-22 contribute to blood-brain barrier disruption (44) .
GM-CSF is a potent mediator of Th17 cell damage during EAE (45) . GM-CSF activates microglia, enhances myeloid cell recruitment, and promotes Th17 cell differentiation (46) (47) (48) . The greatest influence of IL-10 deficiency on Th17 function was increased production of GM-CSF on both a population and single-cell basis. Thus, although a neutralizing antibody did not improve the outcome, GM-CSF cannot be excluded as a contributor to immune-mediated damage in viral encephalomyelitis.
Together, these studies have characterized the functional features of Th17 cells that develop in the absence of IL-10 and have identified pathogenic Th17 and Th1/17 cells as participants in the immunopathologic process leading to fatal viral encephalomyelitis. This understanding of the pathogenesis of acute virus-induced neurologic disease will aid in identifying therapeutic interventions that focus on immune modulation as well as antiviral drugs. IFNγ (C and J), TNFα (E and L), and granzyme B (G and N) was calculated as the mean ± SEM from three independent experiments; *P < 0.05. Gene Ct values were normalized to Gapdh, and fold change was calculated relative to uninfected controls (ΔΔCt). Data are pooled from two independent experiments and presented as the mean ± SEM from four to six mice at each time point; *P < 0.05, **P < 0.01, ***P < 0.001.
Methods and Materials
Animals and Infection. C57BL/6J WT and B6.129P2-Il10 tm1Cgn /J (C57BL/6J IL-10 −/− ) (49) mice were purchased from Jackson Laboratories and bred in house. The NSV strain of Sindbis virus (50) was grown and assayed by plaque formation in BHK cells. For infection, sex-matched 4-6-wk-old mice were inoculated intranasally with 10 5 pfu NSV in 20 μL HBSS. For assessment of morbidity and mortality, mice were monitored daily. The scoring system used was as follows: 0, no signs of disease; 1, abnormal hind-limb and tail posture, ruffled fur, and/or hunched back; 2, unilateral hind-limb paralysis; 3, bilateral hind-limb paralysis or full-body paralysis; 4, dead. For tissue collection, mice were anesthetized with isoflurane and bled by cardiac puncture. Mice were perfused with ice-cold PBS, and brains and spinal cords were collected and used fresh or snap frozen and stored at −80°C. All experiments were performed according to guidelines approved by the Johns Hopkins University Institutional Animal Care and Use Committee.
Virus Assays. Tissue was homogenized in cold PBS to make 10% (wt/vol) brain and spinal cord homogenates and was clarified by centrifugation. Infectious virus was assayed by plaque formation on BHK-21 cells. Data are plotted as the mean of the log 10 value of plaque forming units ± SEM. For statistical purposes, samples in which no virus was detected at a 1:10 dilution were assigned a value of 0.85, halfway between the limit of detection and 0.
Histology. Uninfected and NSV-infected mice at 3, 5, and 7 d after infection were perfused with ice-cold PBS followed by 4% (wt/vol) paraformaldehyde. Brains were removed and cut into 2-mm coronal slices with an adult Mouse Brain Slicer (Zivic Instruments) that were postfixed in 4% (wt/vol) paraformaldehyde for 24 h at 4°C. Slices were washed in PBS and embedded in paraffin. Coronal brain sections (10 μm) were stained with H&E, coded, and scored blindly as previously described (51) using a 0-3 scale: 0, no detectable inflammation; 1, one to two small inflammatory foci per section; 2, moderate inflammatory foci in up to 50% of 10× fields; 3, moderate to large inflammatory foci in greater than 50% of 10× fields. An additional point was added for excessive parenchymal cellularity, allowing for a maximal score of 4.
Mononuclear Cell Isolation. Single-cell suspensions were made from brain and spinal cord tissue homogenized in RPMI + 1% FBS, 1 mg/mL collagenase (Roche), and 0.1 mg/mL DNase (Roche) using the GentleMACS system (Miltenyi). The homogenate was incubated (37°C, 15 min), homogenized again, incubated again, and filtered (70 μm). Myelin debris and red blood cells were removed by centrifugation on a 30/70% percoll gradient for 30 min at 4°C. Mononuclear cells at the interface were collected, resuspended in PBS + 2 mM EDTA, and live cells counted using trypan blue exclusion. Gene Expression Analysis Using Real-Time PCR. RNA was isolated from frozen tissue using the RNeasy Lipid Mini RNA Isolation Kit (Qiagen). RNA was quantified using a nanodrop spectrophotometer, and cDNA was prepared with the High Capacity cDNA Reverse Transcription Kit (Life Technologies) using 0.5-2.5 μg RNA. Quantitative real-time PCR was performed using 2.5 μL cDNA, TaqMan gene expression arrays (Il10, Il17a, and Ccl20), and 2× Universal PCR Mastermix (Applied Biosystems). Gapdh mRNA levels were determined using the rodent primer and probe set (Applied Biosystems). All reactions were run on the Applied Biosystems 7500 real-time PCR machine with the following conditions: 50°C for 2 min, 95°C for 10 min, 95°C for 15 s, and 60°C for 1 min for 50 cycles. Transcript levels were determined by normalizing the target gene Ct value to the Ct value of Gapdh. This normalized value was used to calculate the fold change relative to the average of the uninfected control (ΔΔCt method).
Neutrophil Depletion. Mice were administered 0.5 mg rat anti-Ly6G antibody (clone 1A8, BioXcell) or the rat IgG2a isotype control (clone 3A2, BioXcell) intraperitoneally in 200 μL PBS at the time of infection and 4 d after infection. To document neutrophil depletion, blood smears were examined for the percentage of white blood cells that were neutrophils. To document depletion in the CNS, brains collected 7 d after infection were analyzed by flow cytometry.
Cytokine Neutralization. To neutralize IL-17a, mice were treated with 250 μg of mouse anti-IL-17a (clone 17F3, BioXcell) or the mouse IgG1 isotype control (clone MOPC-21, BioXcell) antibody intraperitoneally in a volume of 200 μL (diluted in PBS) at the time of infection and again at 3 and 6 d after infection. To neutralize GM-CSF, mice were treated with 250 μg of rat anti-GM-CSF (clone MP1-22E9, BioXcell) or the rat IgG2a isotype control (clone 3A2, BioXcell) antibody intraperitoneally in a volume of 200 μL (dlluted in PBS) at 2, 4, 6, and 8 d after infection.
Statistical Analysis. Data from two to four independent experiments or at least three mice per group were used. Survival was compared using KaplanMeier survival curves (log rank test). Differences during the course of infection in a single group were determined using one-way ANOVA and Dunn posttests. Differences between groups during the course of infection were determined using two-way ANOVA and Bonferroni posttests. Differences between groups at a single time point were determined using an unpaired, two-tailed Student t test with a 95% confidence interval. All statistical analyses used Prism 5 (GraphPad).
